A single vial or pen of semaglutide ranges from roughly $200 to over $1,300, depending on whether you’re buying a brand-name product, using a discount program, or have insurance coverage. The sticker price for brand-name Ozempic is $1,028 per month, and Wegovy lists at $1,349 per month. Most people pay significantly less than that through insurance, discount cards, or alternative pharmacy options.
Brand-Name List Prices
Semaglutide is sold under two main brand names. Ozempic, approved for type 2 diabetes, has a list price of $1,028 for a one-month supply. Wegovy, approved for weight management, lists at $1,349 per month. Each monthly supply comes as a pre-filled injection pen rather than a traditional vial, and the price covers four weekly doses.
These list prices are what pharmacies get charged before any negotiations, discounts, or insurance adjustments. They represent the ceiling, not what most patients actually pay. Novo Nordisk, the manufacturer, has announced plans to cut these list prices by up to 50% starting in 2027.
What You’ll Actually Pay Without Insurance
If you’re paying out of pocket, discount programs can cut costs substantially. GoodRx offers an introductory price of $199 per month for the Wegovy injection on your first two fills, or $149 per month for the pill form at certain doses. After that introductory period, the ongoing price is $349 per month for the injection or $299 per month for the pill.
These discount prices don’t require insurance and are available at most major retail pharmacies. The gap between the $1,349 list price and the $349 discount price shows how inflated sticker prices can be relative to what’s actually available to cash-paying customers.
What You’ll Pay With Insurance
Insurance coverage for semaglutide varies widely depending on your plan and why you’re taking it. If your commercial insurance covers semaglutide, copays can be as low as $25 for a one-month supply. If your plan exists but doesn’t cover the drug, you may still access it for around $349 per month through manufacturer discount programs.
Coverage depends heavily on the reason for your prescription. Plans are more likely to cover Ozempic for diabetes management than Wegovy for weight loss. For weight loss coverage, most insurers follow the FDA-labeled criteria: a BMI over 30, or a BMI over 27 with at least one weight-related condition like high blood pressure, type 2 diabetes, or high cholesterol. Some plans impose stricter requirements, only covering patients with a BMI above 30 regardless of other conditions. A smaller number of plans set the bar even higher than that.
Coverage for adolescents aged 12 and older is also available under some plans, based on the FDA’s expanded label for patients at or above the 95th BMI percentile for their age and sex.
Online Provider and Telehealth Costs
Many people access semaglutide through online telehealth platforms that bundle a medical consultation with a prescription. These services charge monthly membership fees on top of the medication cost, and the total varies quite a bit. Weight Watchers Clinic charges $74 per month with an annual commitment. Mochi Health runs $79 for a single month. Hims & Hers charges $149 per month after a $39 introductory first month. Ro’s body program costs $145 per month. A few providers, like Remedy Meds, charge no membership fee at all.
When budgeting for semaglutide through these services, factor in both the membership and the medication. A $79 monthly membership plus a $349 medication cost adds up to over $400 per month, which is still far below the brand-name list price but a meaningful expense over the months or years most people stay on the drug.
Compounded Semaglutide Vials
Some compounding pharmacies have sold semaglutide in traditional vials rather than pre-filled pens. These vials typically combine semaglutide with vitamin B12 and come in concentrations ranging from 1 mg/mL to 5 mg/mL, in either 1 mL or 2.5 mL vial sizes. Pricing and availability for compounded versions have fluctuated significantly due to regulatory changes around compounding pharmacies and semaglutide’s shortage status.
If you’re considering a compounded version, the concentration matters for calculating your actual cost per dose. A 2.5 mL vial at 5 mg/mL contains 12.5 mg of semaglutide total, which could last several weeks depending on your prescribed dose. Compare that to a 1 mL vial at 1 mg/mL, which contains just 1 mg and might cover only a single injection at higher maintenance doses.
Patient Assistance for Low-Income Patients
Novo Nordisk offers a Patient Assistance Program for uninsured patients who can’t afford the medication. For Ozempic, your total household income must be at or below 200% of the federal poverty level. For other Novo Nordisk medications, the threshold is more generous at 400% of the federal poverty level. Patients who qualify receive the medication at no cost. Eligibility details and current poverty level thresholds are available through NovoCare or the NeedyMeds website.
When Generic Semaglutide Could Arrive
Novo Nordisk’s core U.S. patent on semaglutide is set to expire in 2032. However, the company has settled patent lawsuits with several generic manufacturers, and those confidential settlement terms likely include earlier entry dates for generic versions. In markets outside the U.S., patents expire sooner. Until generics arrive, branded and compounded versions remain the only legal options, keeping prices higher than they would be in a competitive generic market.